Related references
Note: Only part of the references are listed.Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform
Tania L. Slatter et al.
BLOOD (2011)
P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
Kelly A. Avery-Kiejda et al.
BMC CANCER (2011)
Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
Tina C. Albershardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment
Jianfeng Lu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Cyclopeptide Smac mimetics as antagonists of IAP proteins
Haiying Sun et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells
C-T Yang et al.
CANCER GENE THERAPY (2010)
Downregulation of caspase-9 is a frequent event in patients with stage II colorectal cancer and correlates with poor clinical outcome
X. -G. Shen et al.
COLORECTAL DISEASE (2010)
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Jennifer P. Morton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Min H. Kang et al.
CLINICAL CANCER RESEARCH (2009)
Inhibitor of apoptosis proteins and apoptosis
Yunbo Wei et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2008)
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator
Sonia Lain et al.
CANCER CELL (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Frank M. Boeckler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia
Markus Jensen et al.
INVESTIGATIONAL NEW DRUGS (2008)
The inhibitor of apoptosis proteins as therapeutic targets in cancer
Domagoj Vucic et al.
CLINICAL CANCER RESEARCH (2007)
Cell death modalities: classification and pathophysiological implications
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2007)
Targeting survivin in cancer therapy: fulfilled promises and open questions
Marzia Pennati et al.
CARCINOGENESIS (2007)
Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy
Rita Bayer Lopes et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cancer-derived p53 mutants suppress p53-target gene expression - potential mechanism for gain of function of mutant p53
Faina Vikhanskaya et al.
NUCLEIC ACIDS RESEARCH (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
New tricks of an old molecule: lifespan regulation by p53
Johannes H. Bauer et al.
AGING CELL (2006)
siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status
Ken Ohnishi et al.
RADIATION RESEARCH (2006)
Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study
PY Fong et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Caspases: pharmacological manipulation of cell death
IN Lavrik et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer
M Ocker et al.
GUT (2005)
Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells
K Kami et al.
SURGERY (2005)
Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy
H Sharma et al.
CANCER BIOLOGY & THERAPY (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Targeting apoptosis pathways in cancer therapy
IM Ghobrial et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells
SL Fink et al.
INFECTION AND IMMUNITY (2005)
Gene transfer of constitutively active caspase-3 induces apoptosis in a human hepatoma cell line
L Cam et al.
JOURNAL OF GENE MEDICINE (2005)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer
C Cao et al.
ONCOGENE (2004)
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
IM Svane et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Morphological features of cell death
U Ziegler et al.
NEWS IN PHYSIOLOGICAL SCIENCES (2004)
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
E Devarajan et al.
ONCOGENE (2002)
Characterization of the p53-rescue drug CP-31398 in vitro and in living cells
TM Rippin et al.
ONCOGENE (2002)
Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern
Y Ashhab et al.
FEBS LETTERS (2001)
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
D Vucic et al.
CURRENT BIOLOGY (2000)
Share Paper
